Secure translational funding
The Translational Research Office (TRO) supports researchers in advancing innovative discoveries toward real-world impact. We manage devolved early-stage proof-of-concept funding and bring extensive expertise in the UK translational funding landscape. From identifying the most appropriate funding scheme to shaping compelling applications, we help projects secure the resources needed to progress along the translational pathway and de-risk future investment.
Our Translational Research Managers provide hands-on support across the project lifecycle, including grant development, strategic positioning, project management, and long-term translational planning. By combining funding expertise with strategic oversight, we help research teams navigate complexity, accelerate progression, and maximise the potential for commercialisation and societal benefit.
Internal translational funding schemes
Details of internal translational funding schemes, including the Medical and Life Sciences Translational Fund, Diagnostics in Tropical and Infectious Diseases and other calls.
External translational funding opportunities
Details of external translational funding opportunities, including calls from charities, industry, UKRI, governmental bodies and other sources.
calls with upcoming deadlines
We would particularly like to draw your attention to these calls:
- Medical and Life Sciences Translational Fund (deadline: 25 September, CRH EOI by 20 July)
- MRC Impact Acceleration Awards (formerly Gap Fund) (deadline: 11 November)
- MRC Proof of Concept Funding (formerly DPFS) (deadline: 18 November)
_________________________________________________________________________________________________________________________________
Other calls with upcoming deadlines:
- NIHR Tackling bacterial and fungal antimicrobial resistance in sub-Saharan Africa and South Asia (deadline: 8 July)
- GHIT Product Development Platform (deadline: EOI by 10 July)
- GHIT Fund Target Research Platform (deadline: EOI by 10 July)
- CRUK Early Detection and Diagnosis Project Award (deadline: 21 July)
- Muscular Dystrophy Project Grants (deadline: 30 July)
- BHF Translational Awards (deadline: 5 August)
- ICURe Discover (Sprint September 2026) (deadline: 20 August, rolling)
- CRH/LifeArc/GOSH C-Further (deadline EOI: 4 September)
- Brain Research UK Project grant (deadline: 4 September)
- UKRI AstraZeneca (AZ) Small molecule high throughput screen using AZ facilities (deadline: 9 September)
- Wellcome Discovery Awards (deadline: 22 September)
- CRUK Therapeutic Catalyst (deadline EOI: 25 September)
